Additionally, immunohistochemistry staining results validated from the Human Protein Atlas database revealed the SESN2 protein to be downregulated in normal tissues and upregulated in endometrial cancer tissues (Figure 1D). The gene discussed is SESN2; the disease is endometrial cancer.